ArticleAntibiotics (Basel, Switzerland)2025

Comparative Outcomes of Meropenem-Vaborbactam vs. Ceftazidime-Avibactam Among Adults Hospitalized with an Infectious Syndrome in the US, 2019-2021.

Marya D Zilberberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.